Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost/Timolol once daily vs Dorzolamide/Timolol twice daily in open-angle glaucoma or ocular hypertension
2005-004767-34Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing Travoprost/Timolol once daily morning with Dorzolamide/Timolol twice daily (2 arms). Primary endpoints: Primary efficacy endpoint and Safety. Started Jan 2006; status: completed.
02
Drugs
travoprost + timololdorzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2005-004767-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004767-34.